Biobridge Europe GmbH
Pharmaceutical Companies · Oberhavel
Biobridge Europe GmbH is a pharmaceutical company based in Oberhavel, Brandenburg, Germany. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).
Content in German
The detailed company information on this page is provided in the original German language. You can use your browser's built-in translation feature to view it in English.
Right-click on the page and select "Translate to English" or use the translation icon in your browser's address bar.
Biobridge Europe GmbH – Address & Contact
Biobridge Europe GmbH Overview
Biobridge Europe GmbH is a pharmaceutical company based in Oberhavel, Brandenburg. The company operates in the German pharmaceutical market and is regulated by the BfArM (Federal Institute for Drugs and Medical Devices).
Activities & Products
Pharmaceutical companies such as Biobridge Europe GmbH develop, produce or distribute medicines for the German and international market. All authorised products are subject to approval and are regulated by BfArM or the European Medicines Agency (EMA).
About Biobridge Europe GmbH
Schleimhautschutz for the oberen Atemwege, Nase, Mand- and Rachenraum and dem Kehlkopf. Hinweise zur Pflege, Prophylaxe and Erkrofkungen.
Location & Contact
Biobridge Europe GmbH can be reached at the following address: Zu den Eichen 5, 16727 Oberhavel – Phone: 033042546501. For current information and enquiries, please contact the company directly.
More information: Pharmaunternehmen in Brandenburg or all Pharmaunternehmen in Germany on Sanoliste.
Pharmazeutische Regulierung in Deutschland
Pharmaceutical companies such as Biobridge Europe GmbH are subject to one of the world's most stringent regulatory frameworks in Germany. The German Medicinal Products Act (AMG) governs the authorisation, manufacturing, distribution and monitoring of medicinal products. Market authorisation for new active substances falls under the responsibility of either the Federal Institute for Drugs and Medical Devices (BfArM) or the European Medicines Agency (EMA), depending on whether a national or centralised authorisation is sought.
Arzneimittelversorgung & Marktumfeld
With a revenue volume exceeding 50 billion euros, the German pharmaceutical market is one of the largest in Europe. Biobridge Europe GmbH, based in Oberhavel, is part of this market. The supply chain from manufacturer through wholesaler to pharmacy is governed by Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP). Since the entry into force of the Act for Greater Safety in the Medicinal Products Supply (GSAV), stricter requirements for the traceability of medicinal products also apply.
Pharmastandort Brandenburg
Brandenburg is a significant pharmaceutical location in Germany. Companies such as Biobridge Europe GmbH benefit from proximity to research institutions, university hospitals and well-developed infrastructure. The industry employs over 140,000 people in Germany and invests billions annually in research and development.
Frequently asked questions about Biobridge Europe GmbH
What does Biobridge Europe GmbH do?
Biobridge Europe GmbH is ein Einzelhandelsundernehmen with medizinischen and orthopädischen Waren. Es offers u.a. rezeptfreie products zur Nasenpflege, verschiedene Arten of Ohrensprays and Mandsprays an.
What medicines does Biobridge Europe GmbH manufacture?
Biobridge Europe GmbH is a pharmaceutical company in Oberhavel. Über Biobridge Europe GmbH Die Biobridge Europe GmbH is ein weltweit agierendes company, the sich on the development and Produktion of hochwertigen biotechnologischen Produ Alle in Germany zugelassenen medicines are in the medicines-Datenbank des BfArM recherchierbar.
How are medicines approved in Germany?
Neue medicines benötigen vor dem Inverkehrbringen eine Zulassung durch the BfArM (national) or the EMA (europaweit). Der Zulassungsprozess umfasst the Prüfung of quality, Wirksamkeit and Unbedenklichkeit on Basis präklinischer and klinischer Stuthen. Die Nutzenbewertung after § 35a SGB V entscheidet about the Erstattung durch the gesetzlichen Krankenkassen.
What does GMP mean in pharmaceutical production?
GMP (Good Manufacturing Practice) bezeichnet the Gute manufacturingspraxis – ein System of qualitysstandards, the sicherstellt, thes medicines gleichbleibend after den gefortheten qualitysnormen hergestellt and geprüft are. Die GMP-Richtlinien are in the EU durch den EudraLex Volume 4 definiert.
Biobridge Europe GmbH on social media
More Pharmaceutical Companies in Oberhavel
Pharmaceutical Companies in Germany
Related areas in healthcare
Pharmaceutical Companies in Brandenburg
All Pharmaceutical Companies in Brandenburg on Sanoliste — or discover all categories by federal state.